Cargando…
Exvivo Experiments of Human Ovarian Cancer Ascites-Derived Exosomes Presented by Dendritic Cells Derived from Umbilical Cord Blood for Immunotherapy Treatment
OBJECTIVES: Exosomes, a type of membrane vesicles, released from tumor cells have been shown to be capable of transferring tumor antigens to dendritic cells and activating specific cytotoxic T-lymphocytes. Recent work has demonstrated the presence of high numbers of exosomes in malignant effusions....
Autores principales: | Li, Qi-Ling, Bu, Ning, Yu, Yue-Cheng, Hua, Wei, Xin, Xiao-Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161644/ https://www.ncbi.nlm.nih.gov/pubmed/21892318 |
Ejemplares similares
-
Expression of Concern for “Exvivo Experiments of Human Ovarian Cancer Ascites-Derived Exosomes Presented by Dendritic Cells Derived From Umbilical Cord Blood for Immunotherapy Treatment”
por: Cho, C.S.
Publicado: (2013) -
Protocol for assessing exvivo lipolysis of murine adipose tissue
por: Roy, Debasish, et al.
Publicado: (2022) -
Dendritic Cell-Derived Exosomes in Cancer Immunotherapy
por: Luo, Shumin, et al.
Publicado: (2023) -
Dendritic cells loaded with tumor derived exosomes for cancer immunotherapy
por: Liu, Hongyu, et al.
Publicado: (2017) -
Umbilical cord blood-derived CD11c(+) dendritic cells could serve as an alternative allogeneic source of dendritic cells for cancer immunotherapy
por: Kumar, Jeetendra, et al.
Publicado: (2015)